Dezherina-Toma Disease

Dezherina-Tom disease is a rare hereditary disease that manifests itself in the form of disorders of the nervous system. This disease was discovered by French scientists J.J. Dejerine and A.A.N. Thomas in 1907, and named after them.

Dezherina-Toma disease is characterized by multiple abnormalities of the nervous system, including sensory disturbances, muscle spasms and paralysis. In most cases, this disease leads to disability and a decrease in the quality of life of patients.

The main cause of the disease is a mutation of the gene, which is responsible for the production of a protein necessary for the normal functioning of the nervous system. This leads to disruption of the transmission of nerve impulses and disruption of the functioning of nervous tissue.

Treatment of dejerin - the volume of the disease consists of the use of drug therapy, physiotherapy and rehabilitation. However, in most cases, treatment does not produce significant results, and patients require constant medical support.

Although dejerine toma disease is a rare disease, it is a serious problem for patients and their families. It is important to conduct research and develop new treatments to improve the quality of life of patients and prevent the spread of the disease throughout the population.

Dejerineau-Thomas disease is a neurological disease that is characterized by the death of nerve cells in the brain, which leads to irreversible changes in the functioning of the central nervous system. This disease was named after two outstanding scientists, French neurologists Jacques-Joseph Dejerine (1848-1920) and Alfredo Annesi Tomasi, who independently discovered it at the beginning of the 20th century. Both scientists explored the symptoms that led to the disease and proposed treatments, but it was not until the 1930s that neurosurgeons began researching and finding new treatments for the disease.

Causes of the disease Dejerineau-Toms disease is a rare and little-studied type of neurological disease that affects the structures of the brain. The exact causes and mechanisms of occurrence of Degerino-Thoms disease remain unclear at the moment, but the most common hypothesis is a deficiency of mitochondrial protein, which leads to damage to brain neurons and the development of this disease. Other possible causes may include hereditary factors, genetic mutations, autoimmune processes and others. When the disease develops, patients experience a high mortality rate within the first year, mainly due to impaired cerebral hemodynamics, as well as from degenerative changes and neural disorders